Benjamin Ely

Intermittent versus Continuous Androgen Deprivation in Prostate Cancer

Maha Hussain, Catherine M. Tangen, Donna L. Berry et al. · New England Journal of Medicine · 2013 · 568 citations · Full text

Medicine, Oncology, Urology +14

Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer

Amir Goldkorn, Benjamin Ely, David I. Quinn et al. · Journal of Clinical Oncology · 2014 · 333 citations · Full text

Medicine, Biostatistics, Oncology +17

Do mixed histological features affect survival benefit from neoadjuvant platinum‐based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group‐Directed Intergroup Study (S8710)

Emil Scosyrev, Benjamin Ely, Edward M. Messing et al. · British Journal of Urology · 2010 · 142 citations · Full text

Medicine, Oncology, Surgery +15

Phase III Trial of Selenium to Prevent Prostate Cancer in Men with High-grade Prostatic Intraepithelial Neoplasia: SWOG S9917

James R. Marshall, Catherine M. Tangen, Wael Sakr et al. · Cancer Prevention Research · 2011 · 116 citations · Full text

Medicine, Oncology, Preventive Medicine +13

Serum Biomarkers of Bone Metabolism in Castration-Resistant Prostate Cancer Patients With Skeletal Metastases: Results From SWOG 0421

Primo N. Lara, Benjamin Ely, David I. Quinn et al. · JNCI Journal of the National Cancer Institute · 2014 · 57 citations

Medicine, Oncology, Pharmacology +17